BioSpace News Archive

The FDA is expected to make a decision on the approval of the proposed new dosage form of granules in packets in 2020.

Investment, benefit and opportunity high but misconceptions and interoperability challenge scaling of AI and telehealth; millennials reluctant to share digital data

HEC Paris, University of Orléans, and the French National Center for Scientific Research are launching cascad, Certification Agency for Scientific Code and Data, the world’s first public laboratory specialized in the certification of the reproducibility of scientific research.

AI Technology Backed by ISO 18587 Certification Supports Lower Cost and Faster Turnaround for Language Services for Device Labeling and Post-Market Surveillance

The National Association of Professional Insurance Agents (PIA National) praised the overwhelming passage in the U.S. House of a bipartisan bill to repeal the provision of the Affordable Care Act (ACA) known to many as the “Cadillac Tax.”

Centinel Spine, LLC, the largest privately-held spine company focused on anterior column reconstruction, today announced that it received Investigational Device Exemption (IDE) approval from the Food and Drug Administration (FDA) to initiate a two-level clinical trial with two different prodisc® C Anterior Cervical Total Disc devices - prodisc C Vivo and prodisc C SK.

Largest dealer in the upper Midwest will serve Minnesota and North Dakota

Medal Recognizes Organizations That Reflect Company’s Commitment to Expanding Access to Care for People in Need

Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) today announced its interim financial results for the second quarter ended May 31, 2019.

ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, August 2, 2019 to discuss its second quarter operating results.